Advertisement

Journal of Molecular Medicine

, Volume 80, Issue 9, pp 610–614 | Cite as

JMM — Past and Present

A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study
  • Stanislaw Winiarczyk
  • Zbigniew Gradski
  • Barbara Kosztolich
  • Cornelia Gabler
  • Gerhardt König
  • Matthias Renner
  • Robert M. Saller
  • Heinrich Prosl
  • Brian Salmons
  • Walter H. Günzburg
  • Johannes Hain
Article

Keywords

Mammary Cancer Encapsulate Cell Cellulose Sulfate Canine Mammary Tumor Primary Mammary Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gordon A (1997) The increasing efficacy of breast cancer treatment. Clin Oncol (R Coll Radiol) 9:338–342CrossRefGoogle Scholar
  2. 2.
    Genka S, Deutsch J, Stahle PL, Shetty UH, John V, Rapoport SI, Greig NH (1990) Brain and plasma pharmacokinetics and anti-cancer activities of cyclophosphamide and phosphoramide mustard in the rat. Cancer Chemother Pharmacol 27:1–7CrossRefPubMedGoogle Scholar
  3. 3.
    Dautzenberg H, Schuldt U, Grasnick G, Karle P, Müller P, Löhr M, Pelegrin M, Piechaczyk M, Von Rombs K, Günzburg WH, Salmons B, Saller RM (1999) Development of cellulose sulphate based polyelectrolyte complex microcapsules for medical applications. Ann NY Acad Sci 875:46–63CrossRefPubMedGoogle Scholar
  4. 4.
    Löhr JM, Hoffmeyer A, Kröger J-C, Freund M, Hain J, Holle A, Karle P, Knöfel WT, Liebe S, Müller P, Nizze H, Renner M, Saller RM, Wagner T, Hauenstein K, Günzburg WH, Salmons B (2001) Microencapsulated cell mediated therapy of inoperable pancreatic carcinoma. Lancet 357:1591–1592CrossRefPubMedGoogle Scholar
  5. 5.
    Kammertöns T, Gelbmann W, Karle P, Saller R, Salmons B, Günzburg WH, Uckert W (2000) Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine. Cancer Gene Ther 7:629–636CrossRefGoogle Scholar
  6. 6.
    Günzburg WH, Karle P, Renz R, Salmons B, Renner M (1999) Characterisation of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy. Ann NY Acad Sci 30:880:326–336CrossRefGoogle Scholar
  7. 7.
    Perez Alenza MD, Pena L, Del Castillo N, Nieto AI (2000) Factors influencing the incidence and prognosis of canine mammary tumours. J Small Anim Pract 41:287–291CrossRefPubMedGoogle Scholar
  8. 8.
    Brodey RS, Goldschmidt MH, Roszel JR (1983) Canine mammary gland neoplasms. J Am Anim Hosp Assoc 19:61–90Google Scholar
  9. 9.
    Simon D, Goronzy P, Stephan I, Meyer-Lindenberg A, Aufderheider M, Nolte I (1996) Mammatumoren beim Hund: Untersuchung zu Vorkommen und Verlauf der Erkrankung. Praktische Tierarzt 9:771–782Google Scholar
  10. 10.
    Kuntze A, Kuntze O (1993) Zur Chirurgie der Mammatumoren bei Hund und Katze. Mh Vet Med 48:467–472Google Scholar
  11. 11.
    Karayannopoulou M, Kaldrymidou E, Constantinidis TC, Dessiris A (2001) Adjuvant post-operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 48:85–96CrossRefPubMedGoogle Scholar
  12. 12.
    Löhr M, Müller P, Karle P, Stange J, Mitzner S, Jesenowski R, Nizze H, Nebe B, Liebe S, Salmons B, Günzburg WH (1998) Targeted chemotherapy by encapsulating cells engineered to deliver CYP2B1, an ifosfamide activating cytochrome P450 gene. Gene Ther 5:1070–1078CrossRefPubMedGoogle Scholar
  13. 13.
    Löhr JM, Bago ZT, Bergmeister H, Ceijka M, Freund M, Gelbmann W, Günzburg, WH, Hain J, Hauenstein K, Henniger W, Hoffmeyer A, Karle P, Kröger J-C, Liebe S, Losert U, Probst A, Renner M, Renz R, Saller R, Salmons B, Schuh M, Wagner T, Walter I (1999) Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intraarterially in patients with advanced stage carcinoma: phase I/II study. J Mol Med 77:393–398CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Stanislaw Winiarczyk
    • 1
  • Zbigniew Gradski
    • 1
  • Barbara Kosztolich
    • 2
  • Cornelia Gabler
    • 4
  • Gerhardt König
    • 3
  • Matthias Renner
    • 5
  • Robert M. Saller
    • 6
  • Heinrich Prosl
    • 7
  • Brian Salmons
    • 5
  • Walter H. Günzburg
    • 2
  • Johannes Hain
    • 6
  1. 1.Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, Agriculture UniversityLublinPoland
  2. 2.Institute of Virology, University of Veterinary MedicineViennaAustria
  3. 3.Institute of Gynacology and Obstetrics, University of Veterinary Medicine, Veterinaerplatz 1ViennaAustria
  4. 4.Institute of Nutrition, University of Veterinary MedicineViennaAustria
  5. 5.AustrianovaViennaAustria
  6. 6.Bavarian NordicMartinsriedGermany
  7. 7.Institute of Parasitology und Zoology, University of Veterinary MedicineViennaAustria

Personalised recommendations